Advanced Colorectal Cancer

Advanced Colorectal Cancer - most related articles:

- CT colonography better for colorectal cancer screening - 7.4
- FDA declines Fusilev NDA for colorectal cancer - 7
- Colorectal cancer deaths are down in US - 6.9
- A genetic trait identified for colorectal cancer risk - 6.4
- Evaluating risk factors of sporadic colorectal cancer - 6.4
- Colonoscopy associated with reduced colorectal cancer incidence - 6.3
- Uninsured diagnosed with an advanced stage cancer - 6
- New class of cancer drugs could work in colon cancers with genetic mutation - 5.6
- New stool test to predict colon cancer - 5.6
- Surgery not necessary for most late stage colorectal cancers - 5.5

Advanced Colorectal Cancer articles

FDA declines Fusilev NDA for colorectal cancer
A Complete Response letter is issued by the U.S. Food and Drug Administration (FDA) regarding the supplemental New Drug Application (sNDA) for FUSILEV (levoleucovorin) for injection for treatment of patients with advanced metastatic colorectal cancer.

Surgery not necessary for most late stage colorectal cancers
A new study shows that a large majority of patients who present with advanced colorectal cancer that has spread to other organs (stage IV) don't require immediate surgery to remove the primary tumor in the colon.

2 Advanced Colorectal Cancer articles listed above.

List health news, Health organizations, Health news world, Glossary, Best health articles, Featured     Go to top

The information provided on Health Newstrack is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. We comply with the HONcode principles for trustworthy health information, and Health News Track is hon code accredited, verify here.
About us, Site map Privacy policy, Disclaimer
© 2007, 2008, 2009, 2010, 2011 HealthNewsTrack.com
3.05